Variables Frequency Percent
Gender    
Male 26 48.1
Female 28 51.9
Types of tumor    
AML 9 16.7
ALL 11 20.4
Ca.Breast 2 3.7
Burkitt's lymphoma 2 3.7
Colorectal carcinoma 15 27.8
HL 3 5.6
NHL 2 3.7
Wilm’stumour 2 3.7
Neuroblastoma 1 1.9
PNET 1 1.9
Osteosarcoma 5 9.3
Multiple Myeloma 1 1.9
Drug groups    
Adriamycine, Bleomycin, DecarbazineVinblastin 2 3.7
Etoposide, Ifosfamide, Mesna 5 9.3
Daunorubicin, Cytosar 6 11.1
Methotrexate, Vincristion, Adriamycine 2 3.7
Daunorubicin, Methotrexate,Cychlophosphamide, Cytosar 4 7.4
Methotrexate, Cytosar, L-asparginase 1 1.9
Daunorubicine, Etoposide, Ifosfamide, Decarbazine, 4 7.4
DoxorubicineCytosar, Vincristin, , L-asparginase 3 5.6
Adriamycine, Bleomycin, Decarbazine, Vincristin 1 1.9
Daunorubicin, Vincristin, L-asparginase, Pridinisolone 1 1.9
Methotrexate, Cychlophosphamide, 5-fluruouracil 2 3.7
5-fluruouracil, Oxaloplatin, Avastin 15 27.8
Methotrexate, Vincristin, Cychlophosphamide, AdriamycineVinblastin, cisplatin, decarbazin, interferon 7 13.0
Total 54 100%
Table 2: Patient characteristics, type of tumor and drug groups.